Mark S. Levine - Net Worth and Insider Trading
Mark S. Levine Net Worth
The estimated net worth of Mark S. Levine is at least $9 Million dollars as of 2024-12-27. Mark S. Levine is the Chief Legal Officer of Immunovant Inc and owns about 319,228 shares of Immunovant Inc (IMVT) stock worth over $8 Million. Mark S. Levine is the General Counsel of Flexion Therapeutics Inc and owns about 133,486 shares of Flexion Therapeutics Inc (FLXN) stock worth over $1 Million. Mark S. Levine is also the SVP,General Counsel & Sec. of Minerva Neurosciences Inc and owns about 0 shares of Minerva Neurosciences Inc (NERV) stock worth over $0. Details can be seen in Mark S. Levine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark S. Levine has not made any transactions after 2024-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark S. Levine
Mark S. Levine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark S. Levine owns 3 companies in total, including Flexion Therapeutics Inc (FLXN) , Minerva Neurosciences Inc (NERV) , and Immunovant Inc (IMVT) .
Click here to see the complete history of Mark S. Levine’s form 4 insider trades.
Insider Ownership Summary of Mark S. Levine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2021-07-19 | General Counsel |
| NERV | Minerva Neurosciences Inc | 2017-06-01 | Vice President,General Counsel |
| IMVT | Immunovant Inc | 2024-11-20 | Chief Legal Officer |
Mark S. Levine Latest Holdings Summary
Mark S. Levine currently owns a total of 3 stocks. Among these stocks, Mark S. Levine owns 319,228 shares of Immunovant Inc (IMVT) as of November 20, 2024, with a value of $8 Million and a weighting of 87.09%. Mark S. Levine owns 133,486 shares of Flexion Therapeutics Inc (FLXN) as of July 19, 2021, with a value of $1 Million and a weighting of 12.91%. Mark S. Levine also owns 0 shares of Minerva Neurosciences Inc (NERV) as of June 1, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Mark S. Levine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMVT | Immunovant Inc | 2024-11-20 | 319,228 | 25.73 | 8,213,736 |
| FLXN | Flexion Therapeutics Inc | 2021-07-19 | 133,486 | 9.12 | 1,217,392 |
| NERV | Minerva Neurosciences Inc | 2017-06-01 | 0 | 2.33 | 0 |
Holding Weightings of Mark S. Levine
Mark S. Levine Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark S. Levine has made a total of 17 transactions in Immunovant Inc (IMVT) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Immunovant Inc is the sale of 3,650 shares on November 20, 2024, which brought Mark S. Levine around $92,893.
According to the SEC Form 4 filings, Mark S. Levine has made a total of 2 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Flexion Therapeutics Inc is the sale of 3,945 shares on July 19, 2021, which brought Mark S. Levine around $25,445.
According to the SEC Form 4 filings, Mark S. Levine has made a total of 0 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years. The most-recent trade in Minerva Neurosciences Inc is the sale of 2,188 shares on June 1, 2017, which brought Mark S. Levine around $192,500.
Insider Trading History of Mark S. Levine
- 1
Mark S. Levine Trading Performance
Mark S. Levine Ownership Network
Mark S. Levine Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Mark S. Levine is the General Counsel of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and Chief Financial Officer David Arkowitz .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Mark S. Levine Mailing Address
Above is the net worth, insider trading, and ownership report for Mark S. Levine. You might contact Mark S. Levine via mailing address: 1601 Trapelo Road, Suite 284, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
